Prot# 2019-SCAR-01: A Phase 2b/3 Randomized, Prospective, Double-Blind, Within-Subject Vehicle Controlled, Multi-Center Study to Determine the Efficacy and Safety of Granexin® Gel (100 µM and 200 µM concentration) in Reducing Scar Formation in Surgical Wo